| Application no. and date | 18829861.6 (espacenet) (Federated) (European Patent Register), 20181221 | | Patent/reg. no. and date | DK/EP 3728313, 20230802 | | Publication date | 20201028 | | Priority no. and date | WO PCT/IB2017/001595, 20171221 | | EP pub. no. and date |
EP 3728313 20201028 | | Effective date | | | Applicant/owner | Debiopharm International S.A., Forum "après-demain"
Chemin Messidor 5-7
1006 Lausanne, CH | | Applicant ref. no. | P83257DK01 | | Inventor | VUAGNIAUX, Grégoire, Rue Orient-Ville 8
1005 Lausanne, CH,
WIEDEMANN, Norbert, Avenue Fantaisie 6
1006 Lausanne, CH,
GAVILLET, Bruno, 430 route de Pitegny
01220 Grilly, FR,
SZYLDERGEMAJN ALTMAN, Sergio Adrian, Chemin des Hirondelles 10
1162 Saint Prex, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-CANCERKOMBINATIONSTERAPI MED EN IAP-ANTAGONIST OG ET ANTI-PD-1-MOLEKYLE | | Int. application no. | EP2018086606 | | Int. publication no. | WO2019122337 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
